Pipeline

1. Lead programme: sepsis

Status: Proof-of-Concept

A one-hour sample-to-answer point-of-care test from whole blood for rapid pathogen ID and AMR profiling. Designed to enable targeted therapy within the first "golden hour".

2. Precision oncology

Status: Exploratory

Leveraging our low-input RNA/DNA nanoarray detection for rapid liquid biopsies, aiming to decentralize early cancer screening and circulating tumour biomarker detection.

3. Future horizons

Status: Concept

Scaling our multiplexing capabilities to address comprehensive panels for rapid targeted therapy companion diagnostics, minimal residual disease and relapse monitoring.

This is the brilliant team making all of this possible.